Tailored Care for Patients With Possible Pneumonia Who Test Positive for Respiratory Viruses

View at publisher Summarise with VIRAT
Authors: Brett Biebelberg, Tom Chen, Cara McKenna, Sanjat Kanjilal, Claire N. Shappell, Chanu Rhee, Michael Klompas
Cited by: 0
References: 8

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

To the Editor—We welcome the opportunity to respond to questions regarding our paper analyzing associations between antibiotic use and outcomes for patients with possible pneumonia who test positive for respiratory viruses [1]. We value scientific debate, but we regret that most of the points raised in the letter misstated our methods, findings, and conclusions [2]. The letter stated: Quite the reverse. Table 2 shows that 2057/6779 (30.3%) of our overall cohort received 0 days of antibiotics and eTable 4 shows that 1190/1720 (69.2%) of patients treated for 0–2 days in the primary analysis received 0 days of antibiotics. In addition, we conducted a sensitivity analysis comparing propensity-weighted outcomes between the 1190 patients treated with 0 days of antibiotics and 894 patients treated with 5–7 days of antibiotics (Figure 2 and eTable 4). We found no significant differences between these groups in hospital length of stay (11.9 vs 11.1 days, adjusted odds ratio [aOR] 1.07, 95% CI .98–1.18), ICU admissions after 48 hours (28.2% vs 27.9%, aOR 1.02, 95% CI .82–1.25), in-hospital mortality (9.0% vs 10.1%, aOR 0.89, 95% CI .60–1.31), or 30-day hospital-free days alive (16.8 vs 17.1, aOR 0.98, 95% CI .93–1.03).

Fields of Study & Subjects

Pneumonia and Respiratory Infections Antibiotic Use and Resistance Respiratory viral infections research

Publication details

Journal / source
Clinical Infectious Diseases
Volume
83
Issue
2
Pages
e448–e449
Publication date
25 March 2026
Language
EN